Nordic Bioscience a/s - Product Pipeline Review - 2014

Published: Dec, 2014 | Pages: 26 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Nordic Bioscience a/s - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Nordic Bioscience a/s - Product Pipeline Review - 2014', provides an overview of the Nordic Bioscience a/s's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Nordic Bioscience a/s's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Nordic Bioscience a/s including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Nordic Bioscience a/s's human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Nordic Bioscience a/s's pipeline products

Reasons to buy

- Evaluate Nordic Bioscience a/s's strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Nordic Bioscience a/s in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Nordic Bioscience a/s's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Nordic Bioscience a/s and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Nordic Bioscience a/s
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Nordic Bioscience a/s and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Nordic Bioscience a/s Snapshot 4
Nordic Bioscience a/s Overview 4
Key Information 4
Key Facts 4
Nordic Bioscience a/s - Research and Development Overview 5
Key Therapeutic Areas 5
Nordic Bioscience a/s - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Partnered Products 9
Partnered Products/Combination Treatment Modalities 10
Nordic Bioscience a/s - Pipeline Products Glance 11
Nordic Bioscience a/s - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Nordic Bioscience a/s - Drug Profiles 12
KBP-042 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
KBP-056 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
KBP-088 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
UGP-302 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Nordic Bioscience a/s - Pipeline Analysis 19
Nordic Bioscience a/s - Pipeline Products by Target 19
Nordic Bioscience a/s - Pipeline Products by Route of Administration 20
Nordic Bioscience a/s - Pipeline Products by Molecule Type 21
Nordic Bioscience a/s - Pipeline Products by Mechanism of Action 22
Nordic Bioscience a/s - Recent Pipeline Updates 23
Nordic Bioscience a/s - Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
Coverage 25
Secondary Research 25
Primary Research 25
Expert Panel Validation 25
Contact Us 26
Disclaimer 26

List of Tables
Nordic Bioscience a/s, Key Information 4
Nordic Bioscience a/s, Key Facts 4
Nordic Bioscience a/s - Pipeline by Indication, 2014 6
Nordic Bioscience a/s - Pipeline by Stage of Development, 2014 7
Nordic Bioscience a/s - Monotherapy Products in Pipeline, 2014 8
Nordic Bioscience a/s - Partnered Products in Pipeline, 2014 9
Nordic Bioscience a/s - Partnered Products/ Combination Treatment Modalities, 2014 10
Nordic Bioscience a/s - Preclinical, 2014 11
Nordic Bioscience a/s - Pipeline by Target, 2014 19
Nordic Bioscience a/s - Pipeline by Route of Administration, 2014 20
Nordic Bioscience a/s - Pipeline by Molecule Type, 2014 21
Nordic Bioscience a/s - Pipeline Products by Mechanism of Action, 2014 22
Nordic Bioscience a/s - Recent Pipeline Updates, 2014 23